These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30478530)

  • 21. Barrett's mucosa, Barrett's dysplasia and Barrett's carcinoma: diagnostic endoscopy without biopsy-taking does not suffice.
    Vieth M; Stolte M
    Dis Esophagus; 2000; 13(1):23-7. PubMed ID: 11005327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot.
    Pilonis ND; Killcoyne S; Tan WK; O'Donovan M; Malhotra S; Tripathi M; Miremadi A; Debiram-Beecham I; Evans T; Phillips R; Morris DL; Vickery C; Harrison J; di Pietro M; Ortiz-Fernandez-Sordo J; Haidry R; Kerridge A; Sasieni PD; Fitzgerald RC
    Lancet Oncol; 2022 Feb; 23(2):270-278. PubMed ID: 35030332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus.
    Pohl H; Rösch T; Vieth M; Koch M; Becker V; Anders M; Khalifa AC; Meining A
    Gut; 2008 Dec; 57(12):1648-53. PubMed ID: 18755886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surveillance for Barrett's oesophagus: worthwhile?].
    Kastelein F; Kuipers EJ
    Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should patients with Barrett's oesophagus be kept under surveillance? The case against.
    Barritt AS; Shaheen NJ
    Best Pract Res Clin Gastroenterol; 2008; 22(4):741-50. PubMed ID: 18656827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
    Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
    Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.
    Hurschler D; Borovicka J; Neuweiler J; Oehlschlegel C; Sagmeister M; Meyenberger C; Schmid U
    Swiss Med Wkly; 2003 Sep; 133(37-38):507-14. PubMed ID: 14652799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference.
    Bibbò S; Ianiro G; Ricci R; Arciuolo D; Petruzziello L; Spada C; Larghi A; Riccioni ME; Gasbarrini A; Costamagna G; Cammarota G
    Dig Liver Dis; 2016 Sep; 48(9):1043-7. PubMed ID: 27436487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oesophageal cell collection device and biomarker testing to identify high-risk Barrett's patients requiring endoscopic investigation.
    Chien S; Glen P; Penman I; Cruickshank N; Bryce G; Crumley A; Phull P; Miller M; Fletcher J; Gunjaca I; Apollos J; Robertson K; Fullarton G
    Br J Surg; 2024 May; 111(5):. PubMed ID: 38736137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival.
    Aldulaimi DM; Cox M; Nwokolo CU; Loft DE
    Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):943-50. PubMed ID: 16093872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines.
    van Sandick JW; Bartelsman JF; van Lanschot JJ; Tytgat GN; Obertop H
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):111-7. PubMed ID: 10656220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic eradication therapy for Barrett's oesophagus: state of the art.
    Kolb JM; Wani S
    Curr Opin Gastroenterol; 2020 Jul; 36(4):351-358. PubMed ID: 32487852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Revision needed of follow-up policy for Barrett's esophagus].
    Giard RW; Coebergh JW; Ouwendijk RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rationale for screening and surveillance of Barrett's metaplasia.
    Wani S; Sharma P
    Best Pract Res Clin Gastroenterol; 2006; 20(5):829-42. PubMed ID: 16997164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant Barrett's oesophagus.
    Li H
    Eur J Cancer Prev; 1993 Jan; 2(1):47-52. PubMed ID: 8428176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.